68--IV Ribovirin

Under the authority of FAR 6.302-1, it is the Governments intent to award a sole source contract to Valeant Pharmaceuticals International, 1 Enterprise, Aliso Viejo, CA 92656, for the purchase of 141 vials of IV Ribovirin: 41 vials of Lot 802404 (1.2gm/12cc) and 100 vials of Lot 03E604 (1.0g/10cc). The IV Ribovirin is essential for use in treatments for Hemorrhagic Fever with Renal Syndrome, Crimean Congo Hemorrhagic Fever and Lassa fever. This is not a formal solicitation. This synopsis is not considered a Request for Quotation or Proposal. No solicitation document is available and telephone requests will not be honored. No contract will be awarded on the basis of offers received in response to this notice. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. If no challenges to acquire this item are received by 4:00 p.m., EST, 20 Jan 2010, the Government reserves the right to execute an award without publishing a solicitation. A determination by the Government not to compete this proposed contract based on this notice is solely within the discretion of the Government. Detailed capabilities must be submitted to contact@example.gov no later than the time and date noted above. After the publication of this announcement for fifteen (15) days, solicitation W81XWH-10-T-00089 will be posted for five (days) Contracting Office Address: US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014 Point of Contact(s): Jeff Sprecher, +1 (555) 000-0000